NCT04339036 2025-12-10
CapTemY90
Abramson Cancer Center at Penn Medicine
Phase 2 Recruiting
Clinical Trials
3 trialsNCT05554003 2024-11-18
MeTe
European Institute of Oncology
Phase 2 Recruiting
NCT06038461 2024-10-01
An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 1/2 Recruiting